+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cosmetic Surgery Market By Gender, By Age Group, By Procedure, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 270 Pages
  • May 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640575
The global cosmetic surgery market was valued at $67,289.1 million in 2021, and is projected to reach $201,025.5 million by 2031, registering a CAGR of 11.6% from 2022 to 2031. Cosmetic surgery is a type of plastic surgery that aims to improve a person’s appearance. It is the unique discipline of medicine focused on enhancing appearance through surgical and medical techniques. Cosmetic surgery can be performed on any part of the face or body. It is a voluntary choice made by a patient to have cosmetic surgery. It includes body contouring, breast enhancement, facial contouring, facial rejuvenation, skin rejuvenation, eyelid surgery, liposuction, rhinoplasty, and facelift. The non-surgical procedure includes botulinum toxin, soft tissue fillers, laser skin resurfacing, microdermabrasion, intense pulsed light, chemical peel, and laser skin resurfacing.
The cosmetic surgery market is driven by increase in number of cosmetic procedures such as body contouring, breast enhancement, facial contouring, increase in demand for aesthetic treatment, rise in awareness regarding skin health, and surge in expenditure on human healthcare services. Moreover, increase in number of key players to launch various cosmetic surgery products boosts growth of the market. Increase in number of licensed medical spas. Rise in self-awareness among young population regarding aesthetic appearance is anticipated to propel growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on cosmetic surgery procedures globally for total consumers. Breast augmentation surgery remains leading aesthetic surgical procedure in the U.S. According to the aesthetic society, over 250,000 primary breast augmentation procedures were performed in the U.S. in 2020. According to the Galderma, one of the aesthetic product manufacturing companies, increase in number of new products for cosmetic surgery also boosts the market. For instance, in January 2021, Candela Syneron, a healthcare equipment manufacturing company, announced the launch of the frax pro system. It is a smarter version of frax dual-depth skin resurfacing device.

However, side effects associated with cosmetic procedures and high cost of surgical cosmetic procedures are anticipated to hinder the market growth during the forecast period. Side effects such as complication related to anesthesia, infection, edema, abnormal scaring, numbness, or nerve damage at the surgical site hinder growth of the market. Development of products with advanced technologies for cosmetic procedures boost demand for cosmetic surgery and provide growth opportunities for the cosmetic surgery market. For instance, in February 2022, Galderma, a pharmaceutical company, announced the launch of alastin skincare reform and repair complex with trihex technology. It is designed to assist in recovery from surgical body procedure.

The global cosmetic surgery market is segmented on the basis of procedure, gender, age group, provider and region. The procedure segment is further bifurcated into breast augmentation, eyelid surgery, liposuction, rhinoplasty and others. On the basis of geneder market is segmented into female and male. On the basis of age group market is segmented into 13 to 29, 30 to 54 and 55 and others. On the basis of provider market is segmented into ambulatory surgical facilities, hospitals & clinics, office & cosmetic surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global cosmetic surgery market include AbbVie Inc., Bausch Health Companies Inc., Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma, and Teoxane Laboratories

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cosmetic surgery market analysis from 2021 to 2031 to identify the prevailingcosmetic surgery market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cosmetic surgery market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cosmetic surgery market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Gender

  • Female
  • Male

By Age Group

  • 13 to 29
  • 30 to 54
  • 55 and above

By Procedure

  • Breast augmentation
  • Eyelid surgery
  • Liposuction
  • Rhinoplasty
  • Others

By End User

  • Ambulatory surgical facility
  • Hospital and clinic
  • Office and cosmetic surgical center

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • India
  • Australia
  • Rest of Asia-Pacific
  • China
  • Japan
  • LAMEA
  • Brazil
  • Saudi Arabia
  • Colombia
  • Rest of LAMEA

Key Market Players

  • Abbvie Inc
  • Bausch Health Companies Inc.
  • Candela Syneron
  • cynosure inc
  • Galderma SA
  • Merz Pharma GmbH and Co. KGaA
  • Sientra Inc
  • Sinclair Pharmaceuticals Limited
  • Teoxane Laboratories
  • Johnson and Johnson

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: COSMETIC SURGERY MARKET, BY PROCEDURE
4.1 Overview
4.1.1 Market size and forecast
4.2 Breast augmentation
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Eyelid surgery
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Liposuction
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Rhinoplasty
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: COSMETIC SURGERY MARKET, BY GENDER
5.1 Overview
5.1.1 Market size and forecast
5.2 Female
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Male
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: COSMETIC SURGERY MARKET, BY AGE GROUP
6.1 Overview
6.1.1 Market size and forecast
6.2 13 to 29
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 30 to 54
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 55 and above
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: COSMETIC SURGERY MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Ambulatory surgical facility
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Hospital and clinic
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Office and cosmetic surgical center
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: COSMETIC SURGERY MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Procedure
8.2.3 North America Market size and forecast, by Gender
8.2.4 North America Market size and forecast, by Age Group
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Procedure
8.2.6.1.2 Market size and forecast, by Gender
8.2.6.1.3 Market size and forecast, by Age Group
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Procedure
8.2.6.2.2 Market size and forecast, by Gender
8.2.6.2.3 Market size and forecast, by Age Group
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Procedure
8.2.6.3.2 Market size and forecast, by Gender
8.2.6.3.3 Market size and forecast, by Age Group
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Procedure
8.3.3 Europe Market size and forecast, by Gender
8.3.4 Europe Market size and forecast, by Age Group
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Procedure
8.3.6.1.2 Market size and forecast, by Gender
8.3.6.1.3 Market size and forecast, by Age Group
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Procedure
8.3.6.2.2 Market size and forecast, by Gender
8.3.6.2.3 Market size and forecast, by Age Group
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Procedure
8.3.6.3.2 Market size and forecast, by Gender
8.3.6.3.3 Market size and forecast, by Age Group
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Procedure
8.3.6.4.2 Market size and forecast, by Gender
8.3.6.4.3 Market size and forecast, by Age Group
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Procedure
8.3.6.5.2 Market size and forecast, by Gender
8.3.6.5.3 Market size and forecast, by Age Group
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Procedure
8.3.6.6.2 Market size and forecast, by Gender
8.3.6.6.3 Market size and forecast, by Age Group
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Procedure
8.4.3 Asia-Pacific Market size and forecast, by Gender
8.4.4 Asia-Pacific Market size and forecast, by Age Group
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Procedure
8.4.6.1.2 Market size and forecast, by Gender
8.4.6.1.3 Market size and forecast, by Age Group
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Procedure
8.4.6.2.2 Market size and forecast, by Gender
8.4.6.2.3 Market size and forecast, by Age Group
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Procedure
8.4.6.3.2 Market size and forecast, by Gender
8.4.6.3.3 Market size and forecast, by Age Group
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Procedure
8.4.6.4.2 Market size and forecast, by Gender
8.4.6.4.3 Market size and forecast, by Age Group
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 Rest of Asia-Pacific
8.4.6.5.1 Market size and forecast, by Procedure
8.4.6.5.2 Market size and forecast, by Gender
8.4.6.5.3 Market size and forecast, by Age Group
8.4.6.5.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Procedure
8.5.3 LAMEA Market size and forecast, by Gender
8.5.4 LAMEA Market size and forecast, by Age Group
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Procedure
8.5.6.1.2 Market size and forecast, by Gender
8.5.6.1.3 Market size and forecast, by Age Group
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Procedure
8.5.6.2.2 Market size and forecast, by Gender
8.5.6.2.3 Market size and forecast, by Age Group
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 Colombia
8.5.6.3.1 Market size and forecast, by Procedure
8.5.6.3.2 Market size and forecast, by Gender
8.5.6.3.3 Market size and forecast, by Age Group
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Procedure
8.5.6.4.2 Market size and forecast, by Gender
8.5.6.4.3 Market size and forecast, by Age Group
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Abbvie Inc
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Bausch Health Companies Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Candela Syneron
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 cynosure inc
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Galderma SA
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Merz Pharma GmbH and Co. KGaA
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Sientra Inc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Sinclair Pharmaceuticals Limited
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Teoxane Laboratories
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Johnson and Johnson
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 2. Cosmetic Surgery Market Revenue, for Breast Augmentation, by Region, 2021-2031, ($Million)
Table 3. Cosmetic Surgery Market for Breast Augmentation by Country, 2021-2031, ($Million)
Table 4. Cosmetic Surgery Market Revenue, for Eyelid Surgery, by Region, 2021-2031, ($Million)
Table 5. Cosmetic Surgery Market for Eyelid Surgery by Country, 2021-2031, ($Million)
Table 6. Cosmetic Surgery Market Revenue, for Liposuction, by Region, 2021-2031, ($Million)
Table 7. Cosmetic Surgery Market for Liposuction by Country, 2021-2031, ($Million)
Table 8. Cosmetic Surgery Market Revenue, for Rhinoplasty, by Region, 2021-2031, ($Million)
Table 9. Cosmetic Surgery Market for Rhinoplasty by Country, 2021-2031, ($Million)
Table 10. Cosmetic Surgery Market Revenue, for Others, by Region, 2021-2031, ($Million)
Table 11. Cosmetic Surgery Market for Others by Country, 2021-2031, ($Million)
Table 12. Global Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 13. Cosmetic Surgery Market Revenue, for Female, by Region, 2021-2031, ($Million)
Table 14. Cosmetic Surgery Market for Female by Country, 2021-2031, ($Million)
Table 15. Cosmetic Surgery Market Revenue, for Male, by Region, 2021-2031, ($Million)
Table 16. Cosmetic Surgery Market for Male by Country, 2021-2031, ($Million)
Table 17. Global Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 18. Cosmetic Surgery Market Revenue, for 13 to 29, by Region, 2021-2031, ($Million)
Table 19. Cosmetic Surgery Market for 13 to 29 By Country, 2021-2031, ($Million)
Table 20. Cosmetic Surgery Market Revenue, for 30 to 54, by Region, 2021-2031, ($Million)
Table 21. Cosmetic Surgery Market for 30 to 54 By Country, 2021-2031, ($Million)
Table 22. Cosmetic Surgery Market Revenue, for 55 and Above, by Region, 2021-2031, ($Million)
Table 23. Cosmetic Surgery Market for 55 and Above by Country, 2021-2031, ($Million)
Table 24. Global Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 25. Cosmetic Surgery Market Revenue, for Ambulatory Surgical Facility, by Region, 2021-2031, ($Million)
Table 26. Cosmetic Surgery Market for Ambulatory Surgical Facility by Country, 2021-2031, ($Million)
Table 27. Cosmetic Surgery Market Revenue, for Hospital and Clinic, by Region, 2021-2031, ($Million)
Table 28. Cosmetic Surgery Market for Hospital and Clinic by Country, 2021-2031, ($Million)
Table 29. Cosmetic Surgery Market Revenue, for Office and Cosmetic Surgical Center, by Region, 2021-2031, ($Million)
Table 30. Cosmetic Surgery Market for Office and Cosmetic Surgical Center by Country, 2021-2031, ($Million)
Table 31. Cosmetic Surgery Market, by Region, 2021-2031, ($Million)
Table 32. North America Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 33. North America Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 34. North America Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 35. North America Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 36. North America Cosmetic Surgery Market, by Country, 2021-2031, ($Million)
Table 37. U.S. Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 38. U.S. Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 39. U.S. Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 40. U.S. Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 41. Canada Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 42. Canada Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 43. Canada Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 44. Canada Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 45. Mexico Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 46. Mexico Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 47. Mexico Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 48. Mexico Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 49. Europe Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 50. Europe Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 51. Europe Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 52. Europe Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 53. Europe Cosmetic Surgery Market, by Country, 2021-2031, ($Million)
Table 54. Germany Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 55. Germany Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 56. Germany Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 57. Germany Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 58. France Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 59. France Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 60. France Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 61. France Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 62. U.K. Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 63. U.K. Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 64. U.K. Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 65. U.K. Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 66. Italy Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 67. Italy Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 68. Italy Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 69. Italy Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 70. Spain Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 71. Spain Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 72. Spain Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 73. Spain Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 74. Rest of Europe Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 75. Rest of Europe Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 76. Rest of Europe Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 77. Rest of Europe Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 78. Asia-Pacific Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 79. Asia-Pacific Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 80. Asia-Pacific Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 81. Asia-Pacific Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 82. Asia-Pacific Cosmetic Surgery Market, by Country, 2021-2031, ($Million)
Table 83. China Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 84. China Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 85. China Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 86. China Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 87. Japan Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 88. Japan Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 89. Japan Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 90. Japan Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 91. India Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 92. India Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 93. India Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 94. India Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 95. Australia Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 96. Australia Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 97. Australia Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 98. Australia Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 99. Rest of Asia-Pacific Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 100. Rest of Asia-Pacific Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 101. Rest of Asia-Pacific Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 102. Rest of Asia-Pacific Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 103. LAMEA Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 104. LAMEA Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 105. LAMEA Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 106. LAMEA Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 107. LAMEA Cosmetic Surgery Market, by Country, 2021-2031, ($Million)
Table 108. Brazil Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 109. Brazil Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 110. Brazil Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 111. Brazil Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 112. Saudi Arabia Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 113. Saudi Arabia Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 114. Saudi Arabia Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 115. Saudi Arabia Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 116. Colombia Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 117. Colombia Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 118. Colombia Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 119. Colombia Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 120. Rest of LAMEA Cosmetic Surgery Market, by Procedure, 2021-2031, ($Million)
Table 121. Rest of LAMEA Cosmetic Surgery Market, by Gender, 2021-2031, ($Million)
Table 122. Rest of LAMEA Cosmetic Surgery Market, by Age Group, 2021-2031, ($Million)
Table 123. Rest of LAMEA Cosmetic Surgery Market, by End-user, 2021-2031, ($Million)
Table 124. Abbvie Inc: Company Snapshot
Table 125. Abbvie Inc: Operating Segments
Table 126. Abbvie Inc: Product Portfolio
Table 127. Abbvie Inc: Net Sales
Table 128. Abbvie Inc: Key Stratergies
Table 129. Bausch Health Companies Inc.: Company Snapshot
Table 130. Bausch Health Companies Inc.: Operating Segments
Table 131. Bausch Health Companies Inc.: Product Portfolio
Table 132. Bausch Health Companies Inc.: Net Sales
Table 133. Bausch Health Companies Inc.: Key Stratergies
Table 134. Candela Syneron: Company Snapshot
Table 135. Candela Syneron: Operating Segments
Table 136. Candela Syneron: Product Portfolio
Table 137. Candela Syneron: Net Sales
Table 138. Candela Syneron: Key Stratergies
Table 139. Cynosure Inc: Company Snapshot
Table 140. Cynosure Inc: Operating Segments
Table 141. Cynosure Inc: Product Portfolio
Table 142. Cynosure Inc: Net Sales
Table 143. Cynosure Inc: Key Stratergies
Table 144. Galderma Sa: Company Snapshot
Table 145. Galderma Sa: Operating Segments
Table 146. Galderma Sa: Product Portfolio
Table 147. Galderma Sa: Net Sales
Table 148. Galderma Sa: Key Stratergies
Table 149. Merz Pharma GmbH and Co. KGaA: Company Snapshot
Table 150. Merz Pharma GmbH and Co. KGaA: Operating Segments
Table 151. Merz Pharma GmbH and Co. KGaA: Product Portfolio
Table 152. Merz Pharma GmbH and Co. KGaA: Net Sales
Table 153. Merz Pharma GmbH and Co. KGaA: Key Stratergies
Table 154. Sientra Inc: Company Snapshot
Table 155. Sientra Inc: Operating Segments
Table 156. Sientra Inc: Product Portfolio
Table 157. Sientra Inc: Net Sales
Table 158. Sientra Inc: Key Stratergies
Table 159. Sinclair Pharmaceuticals Limited: Company Snapshot
Table 160. Sinclair Pharmaceuticals Limited: Operating Segments
Table 161. Sinclair Pharmaceuticals Limited: Product Portfolio
Table 162. Sinclair Pharmaceuticals Limited: Net Sales
Table 163. Sinclair Pharmaceuticals Limited: Key Stratergies
Table 164. Teoxane Laboratories: Company Snapshot
Table 165. Teoxane Laboratories: Operating Segments
Table 166. Teoxane Laboratories: Product Portfolio
Table 167. Teoxane Laboratories: Net Sales
Table 168. Teoxane Laboratories: Key Stratergies
Table 169. Johnson and Johnson: Company Snapshot
Table 170. Johnson and Johnson: Operating Segments
Table 171. Johnson and Johnson: Product Portfolio
Table 172. Johnson and Johnson: Net Sales
Table 173. Johnson and Johnson: Key Stratergies
LIST OF FIGURES
Figure 1. Cosmetic Surgery Market Segmentation
Figure 2. Cosmetic Surgery Market, 2021-2031
Figure 3. Cosmetic Surgery Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Cosmetic Surgery Market:Drivers, Restraints and Opportunities
Figure 12. Cosmetic Surgery Market, by Procedure, 2021 (%)
Figure 13. Comparative Share Analysis of Breast Augmentation Cosmetic Surgery Market, 2021-2031 (%)
Figure 14. Comparative Share Analysis of Eyelid Surgery Cosmetic Surgery Market, 2021-2031 (%)
Figure 15. Comparative Share Analysis of Liposuction Cosmetic Surgery Market, 2021-2031 (%)
Figure 16. Comparative Share Analysis of Rhinoplasty Cosmetic Surgery Market, 2021-2031 (%)
Figure 17. Comparative Share Analysis of Others Cosmetic Surgery Market, 2021-2031 (%)
Figure 18. Cosmetic Surgery Market, by Gender, 2021 (%)
Figure 19. Comparative Share Analysis of Female Cosmetic Surgery Market, 2021-2031 (%)
Figure 20. Comparative Share Analysis of Male Cosmetic Surgery Market, 2021-2031 (%)
Figure 21. Cosmetic Surgery Market, by Age Group, 2021 (%)
Figure 22. Comparative Share Analysis of 13 to 29 Cosmetic Surgery Market, 2021-2031 (%)
Figure 23. Comparative Share Analysis of 30 to 54 Cosmetic Surgery Market, 2021-2031 (%)
Figure 24. Comparative Share Analysis of 55 and Above Cosmetic Surgery Market, 2021-2031 (%)
Figure 25. Cosmetic Surgery Market, by End-user, 2021 (%)
Figure 26. Comparative Share Analysis of Ambulatory Surgical Facility Cosmetic Surgery Market, 2021-2031 (%)
Figure 27. Comparative Share Analysis of Hospital and Clinic Cosmetic Surgery Market, 2021-2031 (%)
Figure 28. Comparative Share Analysis of Office and Cosmetic Surgical Center Cosmetic Surgery Market, 2021-2031 (%)
Figure 29. Cosmetic Surgery Market by Region, 2021
Figure 30. U.S. Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 31. Canada Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 32. Mexico Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 33. Germany Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 34. France Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 35. U.K. Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 36. Italy Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 37. Spain Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 38. Rest of Europe Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 39. China Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 40. Japan Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 41. India Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 42. Australia Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 43. Rest of Asia-Pacific Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 44. Brazil Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 45. Saudi Arabia Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 46. Colombia Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 47. Rest of LAMEA Cosmetic Surgery Market, 2021-2031 ($Million)
Figure 48. Top Winning Strategies, by Year
Figure 49. Top Winning Strategies, by Development
Figure 50. Top Winning Strategies, by Company
Figure 51. Product Mapping of Top 10 Players
Figure 52. Competitive Dashboard
Figure 53. Competitive Heatmap of Top 10 Key Players
Figure 54. Abbvie Inc.: Net Sales, ($Million)
Figure 55. Bausch Health Companies Inc. Net Sales, ($Million)
Figure 56. Candela Syneron.: Net Sales, ($Million)
Figure 57. Cynosure Inc.: Net Sales, ($Million)
Figure 58. Galderma SA.: Net Sales, ($Million)
Figure 59. Merz Pharma GmbH and Co. KGaA.: Net Sales, ($Million)
Figure 60. Sientra Inc.: Net Sales, ($Million)
Figure 61. Sinclair Pharmaceuticals Limited.: Net Sales, ($Million)
Figure 62. Teoxane Laboratories.: Net Sales, ($Million)
Figure 63. Johnson and Johnson.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Cosmetic Surgery Market,' the cosmetic surgery market size was valued at $67.3 billion in 2021, and is estimated to reach $201.0 billion by 2031, growing at a CAGR of 11.6% from 2022 to 2031. Cosmetic surgery is where a person chooses to have an operation or invasive medical procedure to change their physical appearance for aesthetic rather than medical reason. Cosmetic surgery means redesigning body’s contour and shape, smoothing wrinkles, or eliminating balding areas. There are various types of cosmetic surgery procedures that women and men can choose to create an image that makes them feel more confident and comfortable with their appearance. Top cosmetic surgeries are breast augmentation, liposuction, nose reshaping, eyelid surgery, tummy tuck, and facelift. Some non-surgical procedures such as botulinum toxin that temporarily reduces or eliminates facial fine lines and wrinkles. Laser skin resurfacing can reduce facial wrinkles, scars, and blemishes. Microdermabrasion treatments use a minimally abrasive instrument to gently sand skin, removing thicker, uneven outer layer, and has many benefits. According to report share by American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022, total number of surgical and non-surgical procedures is up to 1.4 million in year 2021, and have increased by 40% than 2020.

Factors that drive cosmetic surgery market trends includes increase in number of cosmetic procedures. According to the report share by the American academy of facial plastic and reconstructive surgery, (AAFPRS), it was reported that the number of surgical and non-surgical procedures have been increasing day by day. According to a report by Statista, published in January 2022, the most common cosmetic surgical procedure was breast augmentation. Approximately, 1.6 million augmentation procedures were performed worldwide in 2020. The second most common cosmetic surgical procedure is liposuction and approximately 1.5 million liposuction procedures were performed worldwide in 2020. According to a report by Statista, published in 2021, botulinum toxin is the highest non-surgical procedure performed worldwide. Approximately 2.6 million botulinum toxin procedures were performed in 2020 across the globe. Increase in number of key players to launch various cosmetic surgery products and rise in number approval for the cosmetic surgery products propel the cosmetic surgery market growth. Galderma is a dermatology and pharmaceutical company, which received approval for two products. In May 2020, it received food & drug administration (FDA) approval for restylane kysse, a new hyaluronic acid (ha) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. In February 2021, it received food & drug administration (FDA) approval for restylane defyne for augmentation and correction of mild to moderate chin retrusion for adults over the age of 21. Increase in number of licensed medical spas. The reason behind increasing number of medical spas is attributed to increase in number of non-invasive procedures such as cryolipolysis, laser lipolysis, liposuction, and tummy tuck. These procedures are highly popular among women due to increased levels of self-consciousness and a desire to be beautiful. Increase in skin damage and changes in lifestyle are the major factors that lead to rise in number of medical spas.

The cosmetic surgery market size is segmented procedure, gender, age group, provider, and region.

On the basis of procedure, the market is classified into breast augmentation, eyelid surgery, liposuction, rhinoplasty, and others. The surgical segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of breast augmentation procedures and increase in number of approvals for cosmetic surgeries in breast implant.
On the basis of gender, it is classified into male and female. The female segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in demand for aesthetic procedures, rapidly growing emphasis on personal aesthetics among females, and increase in number of female populations conducting cosmetic surgery.

On the basis of age group, the market is classified into 13 to29, 30 to 54, and 55 and others. The 30 to 54 segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in demand for liposuction and rise in number of cosmetic procedures in population of age group 30-54.

On the basis of provider, the market is classified into ambulatory surgical facilities, hospital and clinics, office & cosmetic surgical center. The hospitals & clinics segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of cosmetic surgeries and rise in number of hospitals and clinics to conduct various surgical procedures.

North America accounted for a majority of the global cosmetic surgery market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of breast augmentation procedures, increase in number of approvals for cosmetic surgery products, presence of cosmetic surgery industry, and advancements in healthcare, medical devices, and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of liposuctions, rise in awareness among young population regarding aesthetics, growth in health care expenditures, and rise in adoption of aesthetic products.

Key findings of the Study

  • By surgical procedure, the breast augmentation segment was the highest contributor to the market in 2021.
  • By gender, the female segment was the highest contributor to the market in 2021.
  • By age group, the 30 to54 segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • By provider, the hospitals & clinics segment was the highest contributor to the market in 2021.
  • By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Abbvie Inc
  • Bausch Health Companies Inc.
  • Candela Syneron
  • cynosure inc
  • Galderma SA
  • Merz Pharma GmbH and Co. KGaA
  • Sientra Inc
  • Sinclair Pharmaceuticals Limited
  • Teoxane Laboratories
  • Johnson and Johnson

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information